Portuguese Registry report on ESRD Fernando Macário (Coimbra)
Portuguese Registry report on Renal Biopsies Fernanda Carvalho (Lisboa)
Chairpersons: José Vinhas (Setúbal), Fernando Nolasco (Lisboa)
CKD: a Global Public Health Problem Chairpersons: João Graça Silva (Lisboa), Mário Campos (Coimbra)
Definition and
classification of kidney disease: Achievements,
controversies and perspectives
Kai-Uwe Eckardt. Erlangen, Germany
Prevalence of CKD and associated
risk factors, and risk of ESRD
José Vinhas. Setúbal, Portugal
Epidemiology of CKD in the
Portuguese population
Salvador Massano Cardoso. Coimbra, Portugal
Coffee break
New Horizons in Glomerulonephritis Chairpersons: Levi Guerra (Porto), Jorge
Pratas (Coimbra)
Diagnosis and treatment of
Minimal Change Nephropathy in adults
Jonathan G. Fox. Glasgow, UK
IgA Nephropathy
Rosanna Coppo. Turin, Italy
Focal and Segmental
Glomerulosclerosis: Pre-renal transplantation studies
Laure-Helen Noel. Paris, France
Collapsing glomerulopathies
Fernanda Carvalho. Lisboa, Portugal
GENZYME Lunch Symposium
Best practice for the treatment of
hyperphosphataemia in early Chronic Kidney Disease (CKD) Chairman: João M. Frazão, Hospital S. João,
Porto
Lunch
Introduction: How to adapt
guidelines to clinical practice?
João M. Frazão, Hospital S. João, Porto
Bone and mineral metabolism
disorders in pre-dialysis – Epidemiological data
from a Low Clearance Outpatient Clinic
Pedro Neves, Hospital Central de Faro
Sevelamer Carbonate – The
relevance of hyperphosphataemia treatment in early
CKD
João M. Frazão, Hospital S. João, Porto
Discussion and concluding
remarks
Hereditary Diseases: What’s New and What’s Next Chairpersons: Helena Jardim (Porto), Elói Pereira (Porto)
When and how to use
molecular genetics in clinical nephrology practice
and investigation
Klaus Zerres. Aachen, Germany
Polycystic Kidney Disease:
Old and new challenges Edgar de Almeida. Lisboa, Portugal
The nephropathy of Fabry’s
disease: Pathology scoring system
João Paulo Oliveira. Porto, Portugal
CO-QU001
PLASMATIC NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN:
GOOD PERFORMANCE AS A BIOMARKER PREDICTOR OF ACUTE
KIDNEY INJURY. PRELIMINARY RESULTS Silvia Coelho; Ana Luísa Papoila; Stela Lopes;
Bruno Rodrigues; Henrique Martins; Francisca Frade;
Karina Soto
CO-QU002
EXCREÇÃO URINÁRIA DE DOPAMINA COMO PREDICTOR DE
ATROFIA TUBULAR E FIBROSE INTERSTICIAL EM DOENTES
COM NEFROPATIA DE IGA E FUNÇÃO RENAL BEM PRESERVADA Liliana Pinho; Joana Santos; Paula Serrão;
Roberto Roncon Albuquerque; Manuel Pestana
CO-QU003
TRANSPLANTE RENAL DE DADOR VIVO: AVALIAÇÃO
RETROSPECTIVA DOS DADORES M. Fructuoso; M. Almeida; L. Martins;
C. Freitas; S. Pedroso; L. Dias; R. Almeida; A. Lhamas;
A. Henriques; A. Cabrita
CO-QU004
PORTUGAL PODE AUMENTAR O NÚMERO DE DADORES
CADAVÉRICOS DE RIM? Margarida Domingos; Miguel Gouveia; Fernando Nolasco;
João Pereira
CO-QU005
OS NÍVEIS DE 25-HIDROXIVITAMINA D3 SÃO PREDITORES DE
MORBILIDADE E MORTALIDADE NOS DOENTES EM HEMODIÁLISE Patrícia Matias; Cristina Jorge;
Carina Ferreira; Marília Borges; Inês Aires;
Tiago Amaral; Célia Gil; José Cortez;
Aníbal Ferreira
CO-QU006
NEFROLOGIA DE INTERVENÇÃO NO ACESSO VASCULAR DE
HEMODIÁLISE - EXPERIÊNCIA DO SERVIÇO DE NEFROLOGIA
DO CHC C Botelho; N Afonso; F Ferrer; K Lopes; P Cotovio;
C Silva; M Camacho; A Marques; Teresa Mendes;
A Carreira
ROCHE symposium Chairpersons: José Augusto Araújo
(Director do Serviço de Nefrologia do Hospital do
Funchal), Ernesto Rocha (Director do Serviço de
Nefrologia do Hospital de Castelo Branco), José Vinhas (Director do Serviço de
Nefrologia do Hospital de Setúbal)
Welcome
Fernando Nolasco, Presidente da Sociedade
Portuguesa de Nefrologia
The PATRONUS study: Final
results
Fernando Carrera, Leading Investigator of the
PATRONUS study
CKD and anaemia in 2010:
the hottest questions
Angel De Francisco, Hospital Universitário
Valdecilla, Santander, Spain
Biosimilars: Clinical
implications of heterogenity
Henrique Luz-Rodrigues, Professor da Faculdade de
Medicina de Lisboa
Prize Giving Ceremony Chairpersons: Fernando Nolasco (Lisboa),
Fernando Carrera (Leiria), José Vinhas
(Setúbal),
Enfº. Boaventura, Enfº. Vilares
Plenary Lecture: 20 years
of experience in the treatment of renal anaemia
Iain C. Macdougall. London, UK
Nomination of Honorary
Members
Prize Giving
FRIDAY,
26th
February | At a glance
Time
Table
08:30 - 10:30
10:30 - 11:00
11:00 - 13:00
13:00 - 14:30
13:00 - 13:15
13:15 - 13:45
13:45 - 14:15
14:15 - 14:30
14:30 - 16:00
Acute Kidney Injury Chairpersons: Carlos Barreto (Setúbal), José Diogo Barata (Carnaxide)
Haemodynamic monitoring and fluid management to prevent
and treat AKI in the ICU
Aníbal Marinho. Porto, Portugal
Risks and benefits of the new AKI staging systems
José António Lopes. Lisboa, Portugal
From AKI to CKD5d. Is AKI a common cause of CKD?
Pedro Ponce. Lisboa, Portugal
Cost-utility impact of treatment decisions for AKI in
the ICU
Patrícia Martins. Porto, Portugal
Coffee break
Improving Long-Term Results in Kidney Transplantation Chairpersons: A. Morais Sarmento (Porto), J. L.
Reimão Pinto (Lisboa)
Immunological monitoring after kidney transplantation
Manuel Arias. Santander, Spain
Chronic humoral rejection
Rui Alves. Coimbra, Portugal
Maintenance immunosupression without anticalcineurinics
agents
Alfredo Mota. Coimbra, Portugal
The effect of induction therapy on long-term results
António Castro Henriques. Porto, Portugal
SHIRE Lunch Symposium
New perspectives in the treatment of hyperphosphataemia with Lanthanum
Carbonate Chairperson: Anibal Ferreira. Lisbon, Portugal
Introduction
The long-term efficacy and safety profile of Lanthanum
Carbonate in preclinical and clinical trials.
Marc De Broe. Antwerp, Belgium
The latest developments of Lanthanum Carbonate in
clinical trials and clinical experience.
Vicente Torregrosa. Barcelona, Spain
Discussion
Current Issues in Haemodialysis Chairpersons: João Ribeiro Santos (Lisboa),
José Augusto Araújo (Funchal)
Renal replacement therapy: Where do we go from here?
Angel LM de Francisco. Santander, Spain
Biofeedback regulation of UF and dialysate conductivity
for prevention of hypotension during dialysis
Antonio Santoro. Bologna, Italy
Strategies for prevention of catheter-related bacteraemia in
haemodialysis patients
Fernando C.Neves. Lisboa, Portugal
16:00 - 17:00
17:00 - 18:00
18:00 - 19:30
Poster presentations
Oral communications. Chairpersons: Margarida S. Gonçalves
(Carnaxide), Teresa Adragão (Carnaxide)
CO-SE007
TRANSPLANTE RENAL DE DADOR VIVO: EXPERIÊNCIA DE UM CENTRO DE TRANSPLANTAÇÃO M. Fructuoso; M. Almeida; L. Martins; C. Freitas; S. Pedroso; L. Dias;
R. Almeida; A. Henriques; A. Cabrita
CO-SE008
ASSOCIAÇÃO ENTRE OS BIOMARCADORES DE RISCO CARDIOVASCULAR EM DIABÉTICOS TIPO2
COM DOENÇA RENAL. Ana Paula Silva; Robson Carmo; Ana Pinho; Ana Cabrita; Anabela Guedes;
Pedro Leão Neves
CO-SE009
FACTORES PREDITORES DE EVENTOS CARDIOVASCULARES NUMA POPULAÇÃO DE DOENTES
TRANSPLANTADOS RENAIS Ana Bernardo; Fernando Macário; Rui Alves; Carlos Alberto; Alfredo Mota
CO-SE010
COLONIZAÇÃO POR MRSA NOS DOENTES EM HEMODIÁLISE Ricardo Santos; Adriana Coutinho; Miguel Furtado; Beatriz Malvar; Rui Silva;
Vítor Ramalho; Filomena Caldeira; Rodrigo Gusmão; Carlos Pires
CO-SE011
BIÓPSIAS RENAIS - A EXPERIÊNCIA NUM SERVIÇO DE NEFROLOGIA Nuno Rodrigues; Joaquim Bordalo; Maria João Galvão; Helena Viana;
Fernanda Carvalho; João Ribeiro Santos
CO-SE012
PRESSÃO ARTERIAL EM HEMODIÁLISE CRÓNICA: O VALOR AMBULATÓRIO DE 44 HORAS;
RELAÇÃO COM O ÍNDICE DE MASSA DO VENTRÍCULO ESQUERDO E PRÓ-BNP Anabela Malho Guedes; Sofia Rocha; Fátima Ferreira; Ernesto Aranda;
Fernanda Silva; José Queirós; Pedro Neves; António Cabrita
AMGEN symposium
Anemia management in CKD patients. A new paradigm? Chairperson: Fernando Carrera. Congress President
Haemoglobin targets – Still moving?
José Vinhas. Setúbal, Portugal
The TREATTM study – Results and impact on clinical
practice
Kai-Uwe Eckardt. Erlangen-Nuremberg, Germany
SATURDAY,
27th
February | At a glance
Time
Table
08:30 - 10:30
10:30 - 11:00
11:00 - 13:00
13:00 - 14:30
14:30 - 16:00
16:00 - 17:00
17:00 - 18:00
18:00
18:00 - 19:30
New Trends in Renal Bone Disease Chairpersons: Aníbal Ferreira (Lisboa),
João Frazão (Porto)
Low turnover bone disease
Jürgen Floege. Aachen, Germany
High turnover bone disease
Mariano Rodriguez. Cordoba, Spain
Osteoporosis in CKD
Neveen Hamdy. Leiden, the Netherlands
Treatment of CKD-MDB.
From old to new drugs: What is the evidence?
Giovanni Strippoli. Santa Maria Imbaro, Italy
Coffee break
Hypertension and CKD: Risk Factors and
Clinical Epidemiology Chairpersons: Pedro Neves (Porto),
Manuel Pestana (Porto)
Sympathetic over-activity in CKD and in ESRD:
Hypertension
and beyond
Francesca Mallamaci. Reggio Calabria, Italy
Arterial stiffness and
the kidney. Relevance to kidney disease progression
Gérard London. Fleury-Mérogis, France
Clinical epidemiology
of hypertension in ESRD patients
Carmine Zoccali. Reggio Calabria, Italy
Antihypertensive
therapy in CKD. Beneficial effects on heart and
kidney: What is the evidence?
Henrique Luz-Rodrigues. Lisboa, Portugal
Lunch Symposium
Peritoneal Dialysis versus Haemodialysis:
Myths and Evidences Chairpersons: Helena Sá (Coimbra), António Cabrita (Porto)
Peritoneal dialysis as
a continuous renal replacement therapy:
comparison with standard haemodialysis
Olof Heimburger. Stockholm, Sweden
Peritoneal dialysis in
high risk patients: Diabetics, Heart failure,
Post Transplant
Miguel Pérez Fontán. Coruña, Spain
Long-term peritoneal dialysis:
A critical problem?
Anabela Rodrigues. Porto, Portugal
Poster presentations
Oral communications. Chairpersons: Jesus Garrido (Viseu), Luís Freitas (Coimbra)
CO-SA013
FACTORES PREDICTORES DE CALCIFICAÇÃO VALVULAR NA
DOENÇA RENAL CRÓNICA Francisca Caetano; Sérgio Barra;
Ana Botelho; Nuno Oliveira; Fátima Costa;
A. Carreira; A. Leitão Marques
CO-SA014
HEMODIAFILTRATION MAY DECREASE THE RISK OF
HOSPITALIZATION IN INCIDENT ESRD PATIENTS Ana Farinha; José Assunção; Carlos Barreto;
Álvaro Vaz; José Vinhas
CO-SA015
FACTORES PREDITORES DE DIABETES MELLITUS APÓS O
TRANSPLANTE RENAL Ana Bernardo; Rui Alves; Fernando Macário;
Margarida Bastos; Carlos Alberto; Alfredo Mota
CO-SA016
VIH E PATOLOGIA RENAL: O QUE MUDOU NOS ÚLTIMOS
ANOS? Paulo Fernandes; Corinne Isnard-Bagnis;
Macroui Sonikian; Isabelle Brocheriou; Armelle Bardier-Dupas;
Frederique Capron; José António Lopes;
António Costa; Gilbert Deray
CO-SA017
EFICÁCIA E SEGURANÇA DO USO DE CINACALCET NO PÓS
TRANSPLANTE RENAL - EXPERIÊNCIA DE UM CENTRO DE
TRANSPLANTAÇÃO Estela Nogueira; Alice Santana; José Guerra;
Sónia Silva; Clara Mil-Homens; António Costa
CO-SA018
TRANSPOSIÇÃO DA VEIA BASÍLICA: EXPERIÊNCIA DE UM
CENTRO Sofia Rocha; José Queirós; Fernanda Silva;
Anabela Malho; Cristina Freitas; Mónica Fructuoso;
Norton Matos; António Cabrita
General Assembly, Portuguese Society of
Nephrology
